Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07149610

Connected Care for Type 2 Diabetes: a Study Protocol for a Structured Self-Management Intervention Through Technology and Healthcare Collaboration

Led by Marche Region Regional Health Agency · Updated on 2025-12-31

388

Participants Needed

13

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a mobile health (m-health) solution designed to support self-management skills in adults with Type 2 Diabetes Mellitus (T2DM) living in the Marche region of Italy. This randomized clinical trial compares the use of the personalized m-health tool integrated with the Electronic Patient Record (EPR) against usual diabetes care, focusing on changes in glycated hemoglobin (HbA1c) levels over an 18-month period. The study aims to enhance patients' abilities to manage their condition through technology combined with healthcare collaboration. Participants are randomly assigned to one of two groups: the treated group receives regular care plus access to the m-health solution, while the control group continues with standard care alone. The m-health solution includes mobile apps for tracking health data such as blood sugar, lifestyle habits, and diet, receiving alerts and motivational messages, communicating with healthcare professionals, and accessing educational materials. Healthcare providers will monitor patient data through an integrated platform and communicate as needed. The intervention begins at diabetic centers and continues at participants' homes. Participants will undergo evaluations at the start and at 6, 12, and 18 months, including clinical assessments, questionnaires, and data collected from the m-health solution. Researchers will assess changes in diabetes severity, medication adherence, lifestyle habits, self-efficacy, quality of life, and the usability and satisfaction with the m-health tool. There are no additional visits or lab tests beyond usual care. The study includes cost-effectiveness analysis and gathers participant feedback to understand their experience with the intervention.

CONDITIONS

Brief Title

Connected Care for Type 2 Diabetes Self-Management

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with Type 2 Diabetes Mellitus by a physician
  • Receiving care at one of the 13 Diabetes Centres in the Marche region, Italy
  • Aged 18 years or older
  • Resident of the Marche region
  • HbA1c level above 7% in the last 3 months
  • No changes in diabetes medication during the previous 6 months
  • Either no hypoglycaemic agents prescribed in the last 4 weeks or stable dose of oral hypoglycaemic agents for more than 12 weeks
  • Own a smartphone or mobile phone with internet access
  • Able to provide informed consent
  • Able to communicate verbally in the local language at a level equivalent to A2 or higher on the CEFR scale
Not Eligible

You will not qualify if you...

  • Recent acute medical problems such as heart attack or stroke within 6 months
  • Physical limitations affecting exercise due to spinal, joint, or neurological conditions
  • Severe conditions like advanced Parkinson's disease, advanced dementia, metastatic cancer, or significant sensory impairments
  • Uncontrolled hypertension or other serious health issues limiting participation
  • Severe depression or other significant psychiatric disorders
  • Estimated kidney function below 30 mL/min/1.73 m2
  • Planned surgery limiting physical activity during the study
  • Pregnancy or breastfeeding
  • Participation in other clinical studies
  • Lack of written informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (in-person)

Treatment

Duration - 18 months

Participants receive either usual care for Type 2 Diabetes Mellitus or usual care plus use a m-health solution integrated with their healthcare system to support self-management of their condition.

Visits with healthcare providers at baseline and at months 6, 12, and 18; ongoing use of mobile applications for monitoring

Trial Site Locations

Total: 13 locations

1

Diabetic Center of Azienda Ospedaliero Universitaria delle Marche

Ancona, Ancona, Italy, 60126

Actively Recruiting

2

Diabetic Center of National Institute for the Care and Treatment of the Elderly (Istituto Nazionale di Ricovero e Cura per Anziani-INRCA)

Ancona, Ancona, Italy, 60127

Actively Recruiting

3

Diabetic Center of Territorial Healthcare Authority of Ancona province

Fabriano, Ancona, Italy, 60044

Not Yet Recruiting

4

Diabetic Center of Territorial Healthcare Authority of Ancona province

Iesi, Ancona, Italy, 60035

Actively Recruiting

5

Diabetic Center of Territorial Healthcare Authority of Ancona province

Senigallia, Ancona, Italy, 60019

Not Yet Recruiting

6

Diabetic Center of Territorial Healthcare Authority of Ascoli Piceno province

Ascoli Piceno, Ascoli Piceno, Italy, 63100

Not Yet Recruiting

7

Diabetic Center of Territorial Healthcare Authority of Ascoli Piceno province

San Benedetto del Tronto, Ascoli Piceno, Italy, 63074

Actively Recruiting

8

Diabetic Center of Territorial Healthcare Authority of Fermo province

Fermo, Fermo, Italy, 63900

Actively Recruiting

9

Diabetic Center of Territorial Healthcare Authority of Macerata province

Civitanova Marche, Macerata, Italy, 62012

Actively Recruiting

10

Diabetic Center of Territorial Healthcare Authority of Macerata province

Province of Macerata, Macerata, Italy, 62100

Actively Recruiting

11

Diabetic Center of Territorial Healthcare Authority of Pesaro Urbino province

Fano, Pesaro-Urbino, Italy, 61032

Actively Recruiting

12

Diabetic Center of Territorial Healthcare Authority of Pesaro Urbino province

Pesaro, Pesaro-urbino, Italy, 61122

Actively Recruiting

13

Diabetic Center of Territorial Healthcare Authority of Pesaro Urbino province

Urbino, Pesaro-Urbino, Italy, 61029

Not Yet Recruiting

Loading map...

Research Team

P

Project Manager

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Efficacy and Safety of the Artificial Intelligence-assisted ...

Diabetes Type 2

Actively Recruiting

1 location

Canagliflozin Targeting Vascular Inflammation: An Ottawa Ima...

Diabetes Type 2

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here